Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

@article{BayesGenis2014HeadtoheadCO,
  title={Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.},
  author={Antoni Bayes-Genis and Marta de Antonio and Joan Castell{\'o} i Vila and Judith Pe{\~n}afiel and Amparo Gal{\'a}n and Jaume Barallat and Elisabet Zamora and Agust{\'i}n Urrutia and Josep Lup{\'o}n},
  journal={Journal of the American College of Cardiology},
  year={2014},
  volume={63 2},
  pages={
          158-66
        }
}
OBJECTIVES ST2 and galectin-3 (Gal-3) were compared head-to-head for long-term risk stratification in an ambulatory heart failure (HF) population on top of other risk factors including N-terminal pro-B-type natriuretic peptide. BACKGROUND ST2 and Gal-3 are promising biomarkers of myocardial fibrosis and remodeling in HF. METHODS This cohort study included 876 patients (median age: 70 years, median left ventricular ejection fraction: 34%). The 2 biomarkers were evaluated relative to… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 84 CITATIONS, ESTIMATED 50% COVERAGE

FILTER CITATIONS BY YEAR

2014
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 12 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Combined Use of the Novel Biomarkers HighSensitivity Troponin T and ST2 for Heart Failure Risk Stratification vs Conventional Assessment

  • J Lupón, M de Antonio, A Galán
  • Mayo Clin Proc
  • 2013
1 Excerpt

Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure

  • A Bayes-Genis, M de Antonio, A Galán
  • Eur J Heart Fail
  • 2012
2 Excerpts